According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:
1. Cigna Group (NYSE:CI)
Cigna Group (NYSE:CI) is the #1 top healthcare plan stock out of 11 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Cigna Group (NYSE:CI) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.
Cigna Group (NYSE:CI) has a Due Diligence Score of 49, which is 10 points higher than the healthcare plan industry average of 39.
CI passed 18 out of 38 due diligence checks and has strong fundamentals. Cigna Group has seen its stock lose -9.08% over the past year, overperforming other healthcare plan stocks by 21 percentage points.
Cigna Group has an average 1 year
price target of $377.77, an upside of 24.57% from Cigna Group's current stock price of $303.27.
Cigna Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Cigna Group, 69.23% have issued a Strong Buy rating, 23.08% have issued a Buy, 7.69% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Cvs Health (NYSE:CVS)
Cvs Health (NYSE:CVS) is the #2 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year.
Learn more.
The Component Grade breakdown for Cvs Health (NYSE:CVS) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: C, and AI: B.
Cvs Health (NYSE:CVS) has a Due Diligence Score of 20, which is -19 points lower than the healthcare plan industry average of 39. Although this number is below the industry average, our proven quant model rates CVS as a "B".
CVS passed 8 out of 38 due diligence checks and has weak fundamentals. Cvs Health has seen its stock return 11.29% over the past year, overperforming other healthcare plan stocks by 42 percentage points.
Cvs Health has an average 1 year
price target of $76.75, an upside of 18.48% from Cvs Health's current stock price of $64.78.
Cvs Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Cvs Health, 50% have issued a Strong Buy rating, 33.33% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Elevance Health (NYSE:ELV)
Elevance Health (NYSE:ELV) is the #3 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year.
Learn more.
The Component Grade breakdown for Elevance Health (NYSE:ELV) is: Value: A, Growth: B, Momentum: D, Sentiment: C, Safety: C, Financials: C, and AI: B.
Elevance Health (NYSE:ELV) has a Due Diligence Score of 51, which is 12 points higher than the healthcare plan industry average of 39.
ELV passed 18 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -36.18% over the past year, underperforming other healthcare plan stocks by -6 percentage points.
Elevance Health has an average 1 year
price target of $488.00, an upside of 43.25% from Elevance Health's current stock price of $340.67.
Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Elevance Health, 66.67% have issued a Strong Buy rating, 22.22% have issued a Buy, 11.11% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.